Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Diosmin versus Cabergoline for OHSS prevention
NCT02134249Phase 3Completed
- Sponsor
- Benha University
- Start
- Apr 2014
- Primary completion
- Sep 2015
- Modality
- Covalent Small Molecules, Classical Binding Small Molecules, Nucleic Acid-Directed Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of diosmin, cabergoline in ovarian hyperstimulation syndrome (OHSS), sponsored by Benha University. Started Apr 2014; status: completed.
02
Drugs
diosmincabergoline
03
Conditions
ovarian hyperstimulation syndrome (OHSS)
Beyond the preview
Go deeper on NCT02134249.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02134249.